Anthropic disclosed in its IPO-related filings that its public advocacy for AI safety regulation could expose the company to government pressure and selective scrutiny, according to Bloomberg. The filing warns that Anthropic may become a target of specific government departments even if similarly situated companies face no such treatment. The risk stems from multiple conflicts with the Trump administration, including disputes over imposing safety restrictions on U.S. Department of Defense use of Anthropic's AI technology, disagreements regarding the safety of the Mythos model, and export control issues. Anthropic further cautioned that future government intervention, export restrictions, and AI-triggered cybersecurity or biosecurity incidents could hinder product deployment, international expansion, and business growth, while the regulatory measures it advocates could increase compliance costs and slow development.